Edges in Network
Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | RIF1 |
Upstream (Parents) |
---|
(<<) PKN2 → RIF1 |
(<<) SGOL2 → RIF1 |
(<<) SMCHD1 → RIF1 |
(<<) PPIG → RIF1 |
(<<) ATRX → RIF1 |
Downstream (Children) |
---|
RIF1 → ARHGAP18 (>>) |
RIF1 → TGS1 (>>) |
RIF1 → KLF13 (>>) |
RIF1 → CHD9 (>>) |
RIF1 → CLIP1 (>>) |
RIF1 → SGOL2 (>>) |
RIF1 → ZNF124 (>>) |
RIF1 → USP1 (>>) |
RIF1 → SMC5 (>>) |
RIF1 → TBL1XR1 (>>) |
RIF1 → DCUN1D1 (>>) |
RIF1 → C20orf94 (>>) |
RIF1 → MYO6 (>>) |
RIF1 → GALNT1 (>>) |
RIF1 → BOD1L (>>) |
RIF1 → SEC22C (>>) |
RIF1 → LPGAT1 (>>) |
RIF1 → C10orf118 (>>) |
RIF1 → KIAA1033 (>>) |
RIF1 → TRIM59 (>>) |
RIF1 → QSER1 (>>) |
RIF1 → UBXN4 (>>) |
RIF1 → ESF1 (>>) |
RIF1 → ANKRD11 (>>) |
RIF1 → CDC42BPA (>>) |
RIF1 → SMCHD1 (>>) |
RIF1 → AASDH (>>) |
RIF1 → TOP1 (>>) |
RIF1 → C1orf104 (>>) |
RIF1 → LARP1B (>>) |
RIF1 → SPATS2 (>>) |
RIF1 → TFAM (>>) |
RIF1 → WASL (>>) |
RIF1 → ZC3H15 (>>) |
RIF1 → NIPBL (>>) |
RIF1 → USP37 (>>) |
RIF1 → G2E3 (>>) |
RIF1 → LOC646891///SDCCAG3 (>>) |
RIF1 → ATRX (>>) |
RIF1 → TNFRSF10A (>>) |
RIF1 → STRAP (>>) |